4.2 Review

Harnessing Metabolomics to Advance Epilepsy Research

Journal

EPILEPSY CURRENTS
Volume 22, Issue 2, Pages 123-129

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/15357597221074518

Keywords

biomarkers; chromatography; epileptogenesis; mass spectrometry; metabolomics; seizure forecasting

Funding

  1. Swebilius Family Trust
  2. National Institutes of Health (NIH) [MD010711, NS109062, NS109734]
  3. National Center for Advancing Translational Sciences (NCATS, a component of the NIH) [RR024139]

Ask authors/readers for more resources

This article introduces the concept and role of metabolomics, emphasizing its importance and uniqueness in the research of complex diseases such as epilepsy. The challenges and solutions in scientific progress and clinical applications of metabolomics are discussed.
Metabolomics is the laboratory analysis and scientific study of the metabolome-that is, the entire collection of small molecule chemicals in an organism. The metabolome represents the functional state of an organism and provides a multifaceted readout of the aggregate activity of endogenous (cellular) and exogenous (environmental) processes. In this review, we discuss how the integrative and dynamic properties of the metabolome create unique opportunities to study complex pathologies that evolve and oscillate over time, like epilepsy. We explain how the scientific progress and clinical applications of metabolomics remain hampered by biological and technical challenges, and we propose best practices to overcome these challenges so that metabolomics can be used in a rigorous and effective manner to further epilepsy research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available